Additional Metadata
Persistent URL dx.doi.org/10.1136/bmjopen-2018-026779, hdl.handle.net/1765/117722
Journal BMJ Open
Citation
de Boer, N.L., van Kooten, J.P., Burger, J.W.A., Verhoef, C, Aerts, J.G.J.V, & Madsen, E.V.E. (2019). Adjuvant dendritic cell based immunotherapy (DCBI) after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal mesothelioma, a phase II single centre open-label clinical trial: rationale and design of the MESOPEC trial. BMJ Open, 9(5). doi:10.1136/bmjopen-2018-026779